Tech Company Financing Transactions
Limbix Funding Round
GSR Ventures, BIXINK Therapeutics and NextGen Venture Partners participated in a $9 million Series A venture round for Limbix. The round was announced on 5/7/2020.
Transaction Overview
Company Name
Announced On
5/7/2020
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for research and development of its flagship product, Limbix Spark, the first prescription digital therapeutic designed to treat adolescents with depression.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
839 Emerson St.
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
Limbix is passionate about delivering mental health treatment to young people who need it the most, when they need it the most. Our team is uniquely suited to develop prescription digital therapeutics, as we understand the value of pairing clinical expertise with technological innovation. Our mission is to improve mental health with accessible technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Lewis
Chief Medical Officer
Marisa Cruz
Chief Operating Officer
Jon Sockell
Chief Technical Officer
Scott Satkin
Vice President
Carmen Rios
VP - R & D
Jessica Lake
VP - R & D
Aarthi Padmanabhan
Browse more venture capital transactions:
Prev: 5/7/2020: Covariant venture capital transaction
Next: 5/7/2020: CoProcure venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs